In silico design of BACE1 inhibitor for alzheimer's disease by traditional chinese medicine

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Huang, Hung Jin ^a   Lee, Cheng Chun ^b   Chen, Calvin Yu Chian ^b,c  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

1M7; 2ALPHA,6ALPHA DIHYDROXYBETULINIC ACID; BENZOYLRAMANONE; BETA SECRETASE INHIBITOR; CHINESE DRUG; DITERPENOID EF D; JANGOMOLIDE; PSEURATA D; SHIONOSIDE C; TRIPTOFODIN B1; UNCLASSIFIED DRUG; VIBSANIN I; ASPARTIC PROTEINASE; BACE1 PROTEIN, HUMAN; LIGAND; MOLECULAR LIBRARY; SECRETASE;

ALZHEIMER DISEASE ASSESSMENT SCALE; ARTICLE; BINDING AFFINITY; BLOOD BRAIN BARRIER; CHINESE MEDICINE; COMPUTER MODEL; CONFORMATION; CONTROLLED STUDY; DATA BASE; LIGAND BINDING; MOLECULAR DYNAMICS; PROTEIN BINDING; STRUCTURE ACTIVITY RELATION; ALZHEIMER DISEASE; ANTAGONISTS AND INHIBITORS; BRAIN; DRUG DATABASE; DRUG EFFECTS; HUMAN; METABOLISM; MOLECULAR LIBRARY; PROCEDURES; THERAPEUTIC USE;

ALZHEIMER DISEASE; AMYLOID PRECURSOR PROTEIN SECRETASES; ASPARTIC ACID ENDOPEPTIDASES; BRAIN; DATABASES, PHARMACEUTICAL; HUMANS; LIGANDS; MEDICINE, CHINESE TRADITIONAL; MOLECULAR DYNAMICS SIMULATION; SMALL MOLECULE LIBRARIES;

EID: 84901753067     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/741703     Document Type: Article

References (68)

1. Mokhtar S. H., Bakhuraysah M. M., Cram D. S., Petratos S., The beta-amyloid protein of alzheimer's disease: communication breakdown by modifying the neuronal cytoskeleton. International Journal of Alzheimer's Disease 2013 2013 15 910502 10.1155/2013/910502
2. Grimm M. O., Mett J., Stahlmann C. P., Neprilysin and abeta clearance: impact of the APP intracellular domain in NEP regulation and implications in Alzheimer's disease. Frontiers in Aging Neuroscience 2013 5, article 98 10.3389/fnagi.2013.00098
3. Petrella J. R., Neuroimaging and the search for a cure for Alzheimer disease. Radiology 2013 269 3 671 691
4. Weinstein J. D., Gonzalez E. R., Egleton R. D., Hunt D. A., A paradigm shift for evaluating pharmacotherapy for Alzheimer's disease: the 10-patient screening protocol. The Consultant Pharmacist 2013 28 7 443 454
5. Ghezzi L., Scarpini E., Galimberti D., Disease-modifying drugs in Alzheimer's disease. Drug Design, Development and Therapy 2013 7 1471 1479
6. Duyckaerts C., Delatour B., Potier M.-C., Classification and basic pathology of Alzheimer disease. Acta Neuropathologica 2009 118 1 5 36 2-s2.0-67349143998 10.1007/s00401-009-0532-1
7. Querfurth H. W., Calcium ionophore increases amyloid β peptide production by cultured cells. Biochemistry 1994 33 15 4550 4561 2-s2.0-0028204224 (Pubitemid 24145103)
8. Morgan D., Diamond D. M., Gottschall P. E., Ugen K. E., Dickey C., Hardy J., Duff K., Jantzen P., DiCarlo G., Wilcock D., Connor K., Hatcher J., Hope C., Gordon M., Arendash G. W., A β peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 2000 408 6815 982 985 2-s2.0-0034700472 10.1038/35050116 (Pubitemid 32101645)
9. McLaurin J., Cecal R., Kierstead M. E., Tian X., Phinney A. L., Manea M., French J. E., Lambermon M. H. L., Darabie A. A., Brown M. E., Janus C., Chishti M. A., Horne P., Westaway D., Fraser P. E., Mount H. T. J., Przybylski M., St George-Hyslop P., Therapeutically effective antibodies against amyloid- β peptide target amyloid- β residues 4-10 and inhibit cytotoxicity and fibrillogenesis. Nature Medicine 2002 8 11 1263 1269 2-s2.0-0036852750 10.1038/nm790 (Pubitemid 35373558)
10. Philippe B., Brion J.-P., Macq A.-F., Octave J.-N., A new monoclonal antibody against the anionic domain of the amyloid precursor protein of Alzheimer's disease. NeuroReport 1993 5 3 289 292 2-s2.0-0027738828 (Pubitemid 24026256)
11. Wilcock D. M., Rojiani A., Rosenthal A., Subbarao S., Freeman M. J., Gordon M. N., Morgan D., Passive immunotherapy against A β in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage. Journal of Neuroinflammation 2004 1 1, article 24 2-s2.0-14244255355 10.1186/1742-2094-1- 24 (Pubitemid 40617823)
12. Wisniewski T., Konietzko U., Amyloid- β immunisation for Alzheimer's disease. The Lancet Neurology 2008 7 9 805 811 2-s2.0-48949085739 10.1016/S1474-4422(08)70170-4
13. Rasool S., Albay R., Martinez-Coria H., Vaccination with a non-human random sequence amyloid oligomer mimic results in improved cognitive function and reduced plaque deposition and micro hemorrhage in Tg2576 mice. Molecular Neurodegeneration 2012 7, article 37 10.1186/1750-1326-7-37
14. Selkoe D. J., Wolfe M. S., Presenilin: running with Scissors in the membrane. Cell 2007 131 2 215 221 2-s2.0-35348860241 10.1016/j.cell.2007.10.012 (Pubitemid 47576152)
15. Yin M.-C., Anti-glycative potential of triterpenes: a mini-review. BioMedicine 2012 2 1 2 9 2-s2.0-84856404500 10.1016/j.biomed.2011.12.001
16. Butini S., Gabellieri E., Brindisi M., A stereoselective approach to peptidomimetic BACE1 inhibitors. European Journal of Medicinal Chemistry 2013 70 233 247
17. Zou Y., Xu L., Chen W., Discovery of pyrazole as C-terminus of selective BACE1 inhibitors. European Journal of Medicinal Chemistry 2013 68 270 283
18. Eketjall S., Janson J., Jeppsson F., AZ-4217: a high potency BACE inhibitor displaying acute central efficacy in different in vivo models and reduced amyloid deposition in Tg2576 mice. The Journal of Neuroscience 2013 33 24 10075 10084
19. Huang H.-J., Yu H. W., Chen C.-Y., Hsu C.-H., Chen H.-Y., Lee K.-J., Tsai F.-J., Chen C. Y.-C., Current developments of computer-aided drug design. Journal of the Taiwan Institute of Chemical Engineers 2010 41 6 623 635 2-s2.0-78649451630 10.1016/j.jtice.2010.03.017
20. Chen C. Y., A novel integrated framework and improved methodology of computer-aided drug design. Current Topics in Medicinal Chemistry 2013 13 9 965 988
21. Tsai T.-Y., Chang K.-W., Chen C. Y.-C., IScreen: world's first cloud-computing web server for virtual screening and de novo drug design based on TCM database@Taiwan. Journal of Computer-Aided Molecular Design 2011 25 6 525 531 2-s2.0-80051545693 10.1007/s10822-011-9438-9
22. Chang K.-W., Tsai T.-Y., Chen K.-C., Yang S.-C., Huang H.-J., Chang T.-T., Sun M.-F., Chen H.-Y., Tsai F.-J., Chen C. Y.-C., iSMART: an integrated cloud computing web server for traditional Chinese medicine for online virtual screening, de novo evolution and drug design. Journal of Biomolecular Structure and Dynamics 2011 29 1 243 250 2-s2.0-79959444251
23. Chen C. Y.-C., TCM Database@Taiwan: the world's largest traditional Chinese medicine database for drug screening In Silico. PLoS ONE 2011 6 1 2-s2.0-79251561193 10.1371/journal.pone.0015939 e15939
24. Lin P.-C., Liu P.-Y., Lin S.-Z., Harn H.-J., Angelica sinensis: a Chinese herb for brain cancer therapy. BioMedicine 2012 2 1 30 35 2-s2.0-84856283501 10.1016/j.biomed.2011.12.003
25. Hsu S. C., Lin J. H., Weng S. W., Crude extract of Rheum palmatum inhibits migration and invasion of U-2 OS human osteosarcoma cells by suppression of matrix metalloproteinase-2 and -9. BioMedicine 2013 3 3 120 129
26. Hsu S. C., Chung J. G., Anticancer potential of emodin. BioMedicine 2012 2 3 108 116
27. Chen K. C., Chang S. S., Tsai F. J., Chen C. Y., Han ethnicity-specific type 2 diabetic treatment from traditional Chinese medicine? Journal of Biomolecular Structure and Dynamics 2013 31 11 1219 1235
28. Tou W. I., Chang S. S., Lee C. C., Chen C. Y., Drug design for neuropathic pain regulation from traditional Chinese medicine. Scientific Reports 2013 3, article 844 10.1038/srep00844
29. Tsou Y. A., Chen K. C., Lin H. C., Chang S. S., Chen C. Y., Uroporphyrinogen decarboxylase as a potential target for specific components of traditional Chinese medicine: a virtual screening and molecular dynamics study. PLoS ONE 2012 7 11 e50087
30. Tou W. I., Chen C. Y.-C., In silico investigation of potential Src kinase ligands from traditional chinese medicine. PLoS ONE 2012 7 3 2-s2.0-84858674458 10.1371/journal.pone.0033728 e33728
31. Chang S.-S., Huang H.-J., Chen C. Y.-C., Two birds with one stone? Possible dual-targeting H1N1 inhibitors from traditional Chinese medicine. PLoS Computational Biology 2011 7 12 2-s2.0-84855282742 10.1371/journal.pcbi.1002315 e1002315
32. Lin C.-H., Chang T.-T., Sun M.-F., Chen H.-Y., Tsai F.-J., Chang K.-L., Fisher M., Chen C. Y.-C., Potent inhibitor design against H1N1 swine influenza: structure-based and molecular dynamics analysis for M2 inhibitors from traditional Chinese medicine database. Journal of Biomolecular Structure and Dynamics 2011 28 4 471 482 2-s2.0-78650945927
33. Chang T.-T., Sun M.-F., Chen H.-Y., Tsai F.-J., Fisher M., Lin J.-G., Chen C. Y.-C., Screening from the world's largest TCM database against H1N1 virus. Journal of Biomolecular Structure and Dynamics 2011 28 5 773 786 2-s2.0-79952209193
34. Chang S.-S., Huang H.-J., Chen C. Y.-C., High performance screening, structural and molecular dynamics analysis to identify H1 inhibitors from TCM Database@Taiwan. Molecular BioSystems 2011 7 12 3366 3374 2-s2.0-80755182421 10.1039/c1mb05320e
35. Chen K.-C., Sun M.-F., Yang S.-C., Chang S.-S., Chen H.-Y., Tsai F.-J., Chen C. Y.-C., Investigation into potent inflammation inhibitors from traditional Chinese medicine. Chemical Biology and Drug Design 2011 78 4 679 688 2-s2.0-80052619174 10.1111/j.1747-0285.2011.01202.x
36. Yang S.-C., Chang S.-S., Chen H.-Y., Chen C. Y.-C., Identification of potent EGFR inhibitors from TCM Database@Taiwan. PLoS Computational Biology 2011 7 10 2-s2.0-80055077153 10.1371/journal.pcbi.1002189 e1002189
37. Yang S.-C., Chang S.-S., Chen C. Y.-C., Identifying HER2 inhibitors from natural products database. PLoS ONE 2011 6 12 2-s2.0-83155183294 10.1371/journal.pone.0028793 e28793
38. Huang H. J., Jian Y. R., Chen C. Y., Traditional Chinese medicine application in HIV: an in silico study. Journal of Biomolecular Structure & Dynamics 2014 32 1 1 12
39. Chen K. C., Jian Y. R., Sun M. F., Investigation of silent information regulator 1 (Sirt1) agonists from Traditional Chinese Medicine. Journal of Biomolecular Structure & Dynamics 2013 31 11 1207 1218
40. Huang H.-J., Lee C.-C., Chen C. Y.-C., Pharmacological chaperone design for reducing risk factor of Parkinson's Disease from Traditional Chinese Medicine. Evidence-Based Complementary and Alternative Medicine 2014 2014 12 830490 10.1155/2014/830490
41. Chen H. Y., Chang S. S., Chan Y. C., Chen C. Y., Discovery of novel insomnia leads from screening traditional Chinese medicine database. Journal of Biomolecular Structure and Dynamics 2014 32 5 776 791 10.1080/07391102.2013. 790849
42. Chen C. Y.-C., Computational screening and design of Traditional Chinese Medicine (TCM) to block phosphodiesterase-5. Journal of Molecular Graphics and Modelling 2009 28 3 261 269 2-s2.0-70349512313 10.1016/j.jmgm.2009.08.004
43. Chen K.-C., Yu-Chian Chen C., Stroke prevention by traditional Chinese medicine? A genetic algorithm, support vector machine and molecular dynamics approach. Soft Matter 2011 7 8 4001 4008 2-s2.0-79953746295 10.1039/c0sm01548b
44. Chen K.-C., Chang K.-W., Chen H.-Y., Chen C. Y.-C., Traditional Chinese medicine, a solution for reducing dual stroke risk factors at once? Molecular BioSystems 2011 7 9 2711 2719 2-s2.0-80051760684 10.1039/c1mb05164d
45. Chang T.-T., Chen K.-C., Chang K.-W., Chen H.-Y., Tsai F.-J., Sun M.-F., Chen C. Y.-C., In silico pharmacology suggests ginger extracts may reduce stroke risks. Molecular BioSystems 2011 7 9 2702 2710 2-s2.0-80051767195 10.1039/c1mb05228d
46. Chen K. Y., Chang S. S., Chen C. Y., In silico identification of potent pancreatic triacylglycerol lipase inhibitors from traditional Chinese medicine. PLoS ONE 2012 7 9 e43932
47. Chen K. C., Chang S. S., Huang H. J., Three-in-one agonists for PPAR-alpha, PPAR-gamma, and PPAR-delta from traditional Chinese medicine. Journal of Biomolecular Structure & Dynamics 2012 30 6 662 683
48. Chou I. C., Lin W. D., Wang C. H., Möbius syndrome in a male with XX/XY mosaicism. BioMedicine 2013 3 2 102 104
49. Lin W.-Y., Liu H.-P., Chang J.-S., Genetic variations within the PSORS1 region affect Kawasaki disease development and coronary artery aneurysm formation. BioMedicine 2013 3 2 73 81
50. Lee C. C., Tsai C. H., Wan L., Increased incidence of Parkinsonism among Chinese with α -glucosidase mutation in central Taiwan. BioMedicine 2013 3 2 92 94
51. Tsai F. J., Rare diseases: a mysterious puzzle. BioMedicine 2013 3 2, article 65
52. Chen C. Y.-C., Weighted equation and rules-a novel concept for evaluating protein-ligand interaction. Journal of Biomolecular Structure and Dynamics 2009 27 3 271 282 2-s2.0-70349903395
53. Lipinski C. A., Lombardo F., Dominy B. W., Feeney P. J., Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews 2001 46 1-3 3 26 2-s2.0-0035289779 10.1016/S0169-409X(00)00129-0 (Pubitemid 33653411)
54. Lipinski C. A., Lead- and drug-like compounds: the rule-of-five revolution. Drug Discovery Today: Technologies 2004 1 4 337 341 2-s2.0-13244266921 10.1016/j.ddtec.2004.11.007 (Pubitemid 40186335)
55. Hunt K. W., Cook A. W., Watts R. J., Spirocyclic beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors: from hit to lowering of cerebrospinal fluid (CSF) amyloid beta in a higher species. Journal of Medicinal Chemistry 2013 56 8 3379 3403
56. Accelrys, Discovery Studio Client v2.5 2009 San Diego, Calif, USA Accelrys
57. Xue B., Dunbrack R. L., Williams R. W., Dunker A. K., Uversky V. N., PONDR-FIT: a meta-predictor of intrinsically disordered amino acids. Biochimica et Biophysica Acta: Proteins and Proteomics 2010 1804 4 996 1010 2-s2.0-76849087968 10.1016/j.bbapap.2010.01.011
58. Brooks B. R., Brooks C. L. III, Mackerell A. D. Jr., Nilsson L., Petrella R. J., Roux B., Won Y., Archontis G., Bartels C., Boresch S., Caflisch A., Caves L., Cui Q., Dinner A. R., Feig M., Fischer S., Gao J., Hodoscek M., Im W., Kuczera K., Lazaridis T., Ma J., Ovchinnikov V., Paci E., Pastor R. W., Post C. B., Pu J. Z., Schaefer M., Tidor B., Venable R. M., Woodcock H. L., Wu X., Yang W., York D. M., Karplus M., CHARMM: the biomolecular simulation program. Journal of Computational Chemistry 2009 30 10 1545 1614 2-s2.0-67650500988 10.1002/jcc.21287
59. Pronk S., Pall S., Schulz R., GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics 2013 29 7 845 854
60. Priyakumar U. D., MacKerell A. D., Comparison of the CHARMM27, AMBER4. 1 and BMS nucleic acid force fields via free energy calculations of base flipping. Abstracts of Papers of the American Chemical Society 2005 230 U1391 U1392
61. Jones J. E., On the determination of molecular fields. II. From the equation of state of a gas. Proceedings of the Royal Society of London Series A 1924 106 738 463 477
62. Buckingham R. A., The classical equation of state of gaseous helium, neon and argon. Proceedings of the Royal Society of London A: Mathematical and Physical Sciences 1938 168 933 264 283
63. Darden T., York D., Pedersen L., Particle mesh Ewald: an N · log(N) method for Ewald sums in large systems. The Journal of Chemical Physics 1993 98 12 10089 10092 2-s2.0-33846823909
64. Essmann U., Perera L., Berkowitz M. L., Darden T., Lee H., Pedersen L. G., A smooth particle mesh Ewald method. The Journal of Chemical Physics 1995 103 19 8577 8593 2-s2.0-33645961739
65. Zoete V., Cuendet M. A., Grosdidier A., Michielin O., SwissParam: a fast force field generation tool for small organic molecules. Journal of Computational Chemistry 2011 32 11 2359 2368 2-s2.0-79958841703 10.1002/jcc.21816
66. Tou W. I., Chen C. Y., May disordered protein cause serious drug side effect? Drug Discovery Today 2014 19 4 367 372 10.1016/j.drudis.2013.10.020
67. Chen C. Y., Tou W. I., How to design a drug for the disordered proteins? Drug Discovery Today 2013 18 19-20 910 915
68. Nie J., Zhou M., Lü C., Hu X., Wan B., Yang B., Li Y., Effects of triptolide on the synaptophysin expression of hippocampal neurons in the AD cellular model. International Immunopharmacology 2012 13 2 175 180 2-s2.0-84860537320 10.1016/j.intimp.2012.03.021